AMA on vitamin D intake
This article was originally published in The Tan Sheet
The American Medical Association calls for FDA to re-examine the Daily Reference Intake Value for vitamin D, according to a June 17 release. Current research on the benefits of vitamin D, including strong bones and reduced breast cancer risk, suggests the prevailing upper limit for adults, which was set in 1997, is "likely overly conservative," AMA says...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.